Results 51 to 60 of about 13,918 (210)

Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring

open access: yesBMC Cancer, 2021
Background Stereotactic Ablative Body Radiotherapy (SABR) is a non-invasive treatment which allows delivery of an ablative radiation dose with high accuracy and precision. SABR is an established treatment for both primary and secondary liver malignancies,
Yoo Young Dominique Lee   +17 more
doaj   +1 more source

Is MRI-Linac helpful in SABR treatments for liver cancer?

open access: yesFrontiers in Oncology, 2023
Objective To determine the MRI-Linac added value over conventional image-guided radiation therapy (IGRT) in liver tumors Stereotactic ablative radiation therapy (SABR). Materials and methods We retrospectively compared the Planning Target Volumes (PTVs),
A. Tallet   +10 more
semanticscholar   +1 more source

Exact analytical solution in the normal SABR model

open access: yes, 2022
S.64-69The Stochastic Alpha Beta Rho (SABR) model by Hagan et al.(2002) is currently one of the most popular models in the interestrate derivative markets.
Tang, S., Korn, R.
core   +1 more source

Current Understanding of Ablative Radiation Therapy in Hepatocellular Carcinoma

open access: yesJournal of Hepatocellular Carcinoma, 2021
Ashwathy S Mathew,1 Laura A Dawson2,3 1Department of Radiation Oncology, Apollo Proton Cancer Centre, Chennai, Tamil Nadu, India; 2Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; 3Department of Radiation Oncology ...
Mathew AS, Dawson LA
doaj  

Advances in Radiobiology of Stereotactic Ablative Radiotherapy

open access: yesFrontiers in Oncology, 2020
Radiotherapy (RT) has been developed with remarkable technological advances in recent years. The accuracy of RT is dramatically improved and accordingly high dose radiation of the tumors could be precisely projected.
Bin Qiu   +4 more
doaj   +1 more source

Increased CD8+CD28+ T cells independently predict better early response to stereotactic ablative radiotherapy in patients with lung metastases from non-small cell lung cancer

open access: yesJournal of Translational Medicine, 2019
Background Stereotactic ablative radiotherapy (SABR) shows a remarkable local control of non-small cell lung cancer (NSCLC) metastases, partially as a result of host immune status. However, the predictors of immune cells for tumor response after SABR are
Chao Liu   +7 more
doaj   +1 more source

Clinical outcomes and lung toxicities after lung SABR using dynamic conformal arc therapy: a single-institution cohort study

open access: yesRadiation Oncology, 2023
Background Stereotactic ablative radiotherapy (SABR) is a validated treatment for early stage lung cancer and pulmonary metastases. It provides a high local control rate with low symptomatic toxicities.
E. Mesny   +5 more
semanticscholar   +1 more source

Intrafraction motion and impact of margin reduction for MR‐Linac online adaptive radiotherapy for pancreatic cancer treatments

open access: yesJournal of Medical Radiation Sciences, Volume 72, Issue 1, Page 17-24, March 2025.
This analysis included quantification of intrafraction motion in pancreas stereotactic ablative radiotherapy treated on the MR‐Linac, leading to the development of adjusted (PTV) margins. Intrafraction motion indicated an average target displacement of 1–3 mm, resulting in an adjusted PTV margin of 2 mm in the right–left and superior–inferior ...
Ashleigh Fasala   +6 more
wiley   +1 more source

Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis

open access: yesRadiation Oncology, 2019
Background This study aimed to compare the clinical outcomes of stereotactic ablative radiotherapy (SABR) and conventionally fractionated radiotherapy (CFRT) in hepatocellular carcinoma (HCC) patients with portal vein invasion (PVI). Methods HCC patients
Jen-Fu Yang   +7 more
doaj   +1 more source

Radiation-Induced Peripheral Neuropathy After Thoracic Stereotactic Ablative Radiotherapy: Case Report

open access: yesJTO Clinical and Research Reports, 2022
Stereotactic ablative radiotherapy (SABR) is a highly effective treatment for medically inoperable patients with early stage NSCLC. Because of its noninvasive nature and favorable toxicity profile, the use of SABR continues to expand for eligible ...
Ha H. Pham, MD, PhD   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy